HCA Healthcare (HCA)
(Delayed Data from NYSE)
$322.86 USD
+0.15 (0.05%)
Updated May 17, 2024 04:00 PM ET
After-Market: $322.73 -0.13 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Brokerage Reports
HCA Healthcare, Inc. [HCA]
Reports for Purchase
Showing records 221 - 240 ( 284 total )
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Positive On Management Plans to Address Company-Specific Issues; Reit OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Expanded Buyback Authorization to Help Offset Higher Cost Trends
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
3Q15 First Look: $1.82B vs Cons $1.85B Driven by Higher Than Expected Salary Expense
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
3Q15 EBITDA Previewed at $1.82B vs Cons $1.88B Driven by Disappointing Payer Mix and High Labor Costs
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
EBITDA Miss Owing to Cost and Mix Pressures; Volumes Remain
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
3Q15 Preview: Finding Buying Opportunities For Top Picks With Strong Fundamentals,Comfortable on Commercial Cost Trends Post Survey
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
3Q15 Preview: Finding Buying Opportunities For Top Picks With Strong Fundamentals, Comfortable on Commercial Cost Trends Post Survey
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
3Q15 Preview: Finding Buying Opportunities For Top Picks With Strong Fundamentals, Comfortable on Commercial Cost Trends Post Survey
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Fundamentals Intact With Reform Driven Growth Still Ramping Up
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
HCA 2Q15 Adj EBITDA $2.01B vs Consensus $1.97B Driven By Better Than Expected Equivalent Admissions; EPS Guidance Raised To High End of Prior Range
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
2Q15 Adj EBITDA $2.01B vs Consensus $1.97B Driven By Better Than Expected Equivalent Admissions
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Leveling of Reform Benefits Not a Major Issue for HCA
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
HCA Previews 2Q15 Adj EBITDA $2.008B vs Consensus $1.96B Driven By Better Than Expected Equivalent Admissions; Guidance Raised To Now Exceed Consensus
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
HCA Previews 2Q15 Adj EBITDA $2.008B vs Consensus $1.96B Driven By Better Than Expected Equivalent Admissions; Guidance Raised To Now Exceed Consensus
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
2Q15 Preview: Raising Estimates on Positive Commercial Cost Trend Outlook and TX Bonus for MOH
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
SCOTUS Rules to Maintain Subsidies in Federal Exchanges; We See This Most Impactful for HCA, THC, and CYH in Removing Risk to 4.1-6.8% of 2016E EBITDA
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
SCOTUS Rules to Maintain Subsidies in Federal Exchanges; We See This Most Impactful for HCA, THC, and CYH in Removing Risk to 4.1-6.8% of 2016E EBITDA
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S